Standardized versus nonstandardized pharmacologic treatment for hepatorenal syndrome

Eur J Gastroenterol Hepatol. 2021 Oct 1;33(10):1334-1335. doi: 10.1097/MEG.0000000000002096.

Authors

Yucel Ustundag¹, Zeki Karasu², Yonca Yilmaz Urun¹

Affiliations

¹ Department of Gastroenterology and Hepatology, School of Medicine, Zonguldak Bulent Ecevit University, Zonguldak, Turkey.
² Gastroenterology and Hepatology, School of Medicine, Ege University, Izmir, Turkey.

PMID: 34581691
DOI: 10.1097/MEG.0000000000002096

No abstract available

Publication types

Letter
Comment

MeSH terms

Hepatorenal Syndrome* / diagnosis
Hepatorenal Syndrome* / drug therapy
Humans
Lypressin
Terlipressin

Substances

Lypressin
Terlipressin